Back

Mineralocorticoid receptor antagonist.

26 May 2019 (08:30 - 08:45)
Organised by:
Congress Presentation Part of: Emerging treatment options in HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Sacubitril/Valsartan.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
sGC stimulators.
Professor B. Pieske (Rostock, DE)
Slides Video
Presentation thumbnail
Interatrial shunt
Professor W. Abraham (Columbus, US)
Slides Video
Presentation thumbnail
SGLT-2 inhibitors.
Professor P. Seferovic (Belgrade, RS)
Slides Video
Presentation thumbnail
Intravenous iron.
Professor S. von Haehling (Goettingen, DE)
Slides Video

Access the full session

Session thumbnail
Emerging treatment options in HFpEF

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Presentation
A safety and pharmacodynamic study of the highly selective aldosterone synthase inhibitor PB6440 in the cynomolgus monkey
26 August 2022
thumbnail
Congress Session
Novel drug therapies in hypertension: new kids on the block
2 September 2024
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources